Monika Vnuk
Tracked across 1 events · 6 articles · First seen Sep 22, 2026 · Last active Sep 22, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on RNA medicines, announced on September 22, 2026 the appointment of Monika Vnuk, MD, as Chief Business Officer, a newly created leadership role. Dr.…
Impact: Monika Vnuk is the appointee, joining Wave Life Sciences as Chief Business Officer and receiving a 375,000-share stock option grant. Her extensive business development experience at Sanofi, Blackstone, and Pfizer is expected to benefit Wave's growth.
Sep 22, 2026 · 6 articles
85
Wave Life Sciences appointed Monika VnukWave Life Sciences...
50
Wave Life Sciences granted stock options Monika VnukWave Life Sciences...
ERGEN INTELLIGENCE
Track Monika Vnuk live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard